Infectious disease
SARS-CoV-2 Surface GP A2 1220–1228 (HLA-A*02:01)
€106.60*
Prices excl. VAT plus shipping
costs
Available, delivery time:
1-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Product number: EP14596_1
Description
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane glycoprotein (M), hemagglutinin-esterease dimer (HE), envelope protein (E), nucleocapsid protein (N), spike or surface glycoprotein (S) and others. The surface glycoprotein is present on the coronavirus envelope and it binds to the ACE2 protein on the host cell surface. SARS-CoV-2 Surface GP A2 1220–1228 (HLA-A*02:01) is a linear peptidic epitope studied as part of surface glycoprotein from severe acute respiratory syndrome-related coronavirus.
TechData
| Sequence: | FIAGLIAIV |
| Delivery: | 1-3 days |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Species: | SARS-CoV-2 |
| Allele: | HLA-A*02:01 |
| Application: | Flow Cytometry |
| Indication: | Infectious disease |
| Purity: | 95% HPLC-MS |